ARTICLE | Management Tracks

Memo names Erik van den Berg as CEO

Plus: Martin Murphy stepping down as Syncona chair, and updates from Red Tree, OMass and Anagenex

November 17, 2023 2:17 AM UTC

Erik van den Berg became CEO of Memo Therapeutics AG, an infectious disease and cancer company. Van den Berg is chairman at Step Pharma S.A.S. and TargED Biopharmaceuticals B.V., and was CEO of AM-Pharma B.V.

CEO Chris Hollowood will take on the role of interim chairman of Syncona Ltd. (LSE:SYNC), after co-founder Martin Murphy stepped down. Murphy will continue to represent Syncona on the boards of Autolus Therapeutics plc (NASDAQ:AUTL), Anaveon AG and Clade Therapeutics Inc. ...